Afya Limited reports financial, regulatory and capital-allocation developments for a Brazil-based medical education group and medical practice solutions provider. The company serves medical students and physicians through an end-to-end ecosystem that includes undergraduate medical education, residency preparation, continuing medical education, graduate programs and practice-management solutions.
Recurring company developments include IFRS financial results in Brazilian reais, medical-seat authorizations from Brazil’s Ministry of Education, campus-level capacity changes, credit-rating actions, dividends, share repurchases and board changes. Afya also reports activity in continuing education, B2B revenue, clinical management tools and the broader physician base that uses its education and medical practice platforms.
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education group in Brazil, announced the resignation of Mrs. Shobhna Mohn from its Board of Directors, effective June 30, 2024. Mohn's departure is unrelated to Afya’s operations or practices. During her tenure, she contributed significantly to Afya's growth, supporting its journey to becoming a top medical education and practice solutions provider in Brazil. Afya highlighted her strategic insights and leadership as pivotal to its success. The company has no immediate plans to fill her position. The board remains committed to strong governance with diverse skills and experience.
Afya (Nasdaq: AFYA; B3: A2FY34), a leading medical education and practice solutions provider in Brazil, announced the successful passage of a key resolution at its Annual General Meeting on June 5, 2024. Shareholders approved and ratified the company's financial statements and the auditor’s report for the fiscal year ending December 31, 2023.
Afya has announced its Annual General Meeting (AGM) scheduled for June 5, 2024, at 10:00 a.m. BRT. The meeting will take place at their Nova Lima office and virtually through a provided link. The main agenda item is the approval and ratification of the company's financial statements and the auditor's report for the fiscal year ending December 31, 2023. The record date for shareholders eligible to attend is May 10, 2024. The company encourages shareholders to participate and vote, either in person or via proxy. The company's financial statements are available on their investor relations website.
Afya reported solid financial results for the first quarter of 2024, with a 13.3% increase in net revenue to R$804.2 million and a 20.5% growth in adjusted EBITDA to R$397.9 million, leading to an adjusted EBITDA margin expansion of 300 bps. The company also saw significant increases in net income and adjusted net income. Afya's ecosystem reached 334,368 users, reflecting its strong presence in the medical education and practice solutions market in Brazil. The company reaffirmed its guidance for 2024, aiming for continued growth and acquisitions to enhance its offerings.
Afya has announced the acquisition of Unidompedro and Faculdade Dom Luiz, adding 300 medical school seats in Brazil. The purchase price is R$660.0 million, with payment split between cash and installments. The transaction is subject to regulatory approval.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.